Dr. Artur Kokornaczyk

AstraZeneca

2023 – Present

Strategic leadership for advanced Lung Cancer therapies. Focused on integrating AI-driven insights into Integrated Medical Action Plans and driving cross-functional innovation.

AstraZeneca

2019 – 2023

Successfully managed 5 product launches in Breast Cancer. Spearheaded omnichannel strategies and modernized KOL engagement through digital initiatives like Brustkrebs.de

AstraZeneca

2017 – 2019

Field medical role in solid tumors characterized by project-based work with KOLs. This approach provided critical insights into HCP needs and the importance of precise scientific exchange.

Bayer

2016 – 2017

Field medical role focused on cardiovascular health. Gained deep insights into the needs of HCPs and the importance of evidence-based communication.

×